SCHEMBL23358348

SCHEMBL23358348

Nc1nc(Cl)c2ncn([C@H]3C[C@@H](CO)C3)c2n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHCY P23526 1/20 0.48
NT5E P21589 1/20 0.43
PDE4D Q08499 2/20 0.43
NR1I2 O75469 1/20 0.43
ALB P02768 1/20 0.43
LMNA P02545 2/20 0.43
TP53 P04637 2/20 0.43
PNP P00491 1/20 0.42
HTT P42858 1/20 0.42
PDE3A Q14432 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
HDAC6 Q9UBN7 2/20 0.41
ADCY5 O95622 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
ADORA3 P0DMS8 1/20 0.40
ADORA2A P29274 1/20 0.40
ADORA2B P29275 1/20 0.40
ADORA1 P30542 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23358343 0.99 AHCY (0.47) AHCYNT5EPDE4DNR1I2ALB
SCHEMBL9311466 0.92 AHCY (0.54) AHCYNT5EPDE4DNR1I2ALB
SCHEMBL9208531 0.91 ADCY5 (0.49) AHCYNT5EPDE4DNR1I2ALB
SCHEMBL9767445 0.91 ADCY5 (0.49) AHCYNT5EPDE4DNR1I2ALB
SCHEMBL9208537 0.91 ADCY5 (0.49) AHCYNT5EPDE4DNR1I2ALB
SCHEMBL23358323 0.88 AHCY (0.62) AHCYPDE4DNR1I2ALBLMNA
SCHEMBL21635511 0.86 AHCY (0.48) AHCYPDE4DNR1I2ALBADCY5
SCHEMBL7140801 0.86 AHCY (0.52) AHCYNT5EPDE4DNR1I2ALB
SCHEMBL7140807 0.86 AHCY (0.52) AHCYNT5EPDE4DNR1I2ALB
SCHEMBL7097329 0.86 AHCY (0.52) AHCYNT5EPDE4DNR1I2ALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12202850-B2 Cyclobutyl purine derivative or salt thereof FUJIFILM CORPORATION (JP) 2025-01-21 US disclosed
US-20230295202-A1 CYCLOBUTYL PURINE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2023-09-21 US disclosed
US-20230295202-A1 CYCLOBUTYL PURINE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2023-09-21 US disclosed
US-20230295202-A1 CYCLOBUTYL PURINE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2023-09-21 US disclosed
EP-3831836-B1 CYCLOBUTYL PURINE DERIVATIVE OR SALT THEREOF FUJIFILM CORP (JP) 2023-09-06 EP disclosed
EP-3831836-A1 CYCLOBUTYL PURINE DERIVATIVE OR SALT THEREOF FUJIFILM Corporation (JP) 2021-06-09 EP disclosed
US-20210147456-A1 CYCLOBUTYL PURINE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2021-05-20 US disclosed
US-20210147456-A1 CYCLOBUTYL PURINE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295202-A1 CYCLOBUTYL PURINE DERIVATIVE OR SALT THEREOF SLC28A1, SLC20A1, SLC29A1 AHCY 1504/4885NT5E 742/4885PDE4D 1004/4885
US-20210147456-A1 CYCLOBUTYL PURINE DERIVATIVE OR SALT THEREOF SLC28A1, SLC20A1, SLC29A1 AHCY 1504/4885NT5E 742/4885PDE4D 1004/4885
US-12202850-B2 Cyclobutyl purine derivative or salt thereof SLC28A1, SLC20A1, SLC29A1 AHCY 1504/4885NT5E 742/4885PDE4D 1004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.